Basic Search  |  Summaries  |  Advanced Search

Violation Tracker Individual Record

Company: GlaxoSmithKline PLC
Current Parent Company: GlaxoSmithKline
Penalty: $65,000,000
Year: 2005
Date: April 22, 2005
Offense Group: competition-related offenses
Primary Offense: price-fixing or anti-competitive practices
Secondary Offense: generic drug pay for delay
Mega-Scandal: Generic Drug Pay for Delay
Violation Description: GlaxoSmithKline agreed to pay $65 million to end-payor purchaser plaintiffs to settle litigation alleging that it improperly blocked the introduction of a generic version of its anti-depressant drug Paxil.
Level of Government: federal
Action Type: private litigation
Court: Eastern District of Pennsylvania
Civil or Criminal Case: civil
Case ID: 2:00cv6222
Case Name: Nichols, et al v. Smithkline Beecham, et al
Private Lawsuit Resolution Type: settlement
HQ Country of Current Parent: United Kingdom
Ownership Structure of Current Parent: publicly traded
Major Industry of Current Parent: pharmaceuticals
Specific Industry of Current Parent: pharmaceuticals
Source of Data: (click here)
Link to PACER Case Docket (must be logged in): (click here)
Link to Archived Court Document:  subscribe to see this data field
Source Notes: If an online information source is not working, check the Violation Tracker Data Sources page for an updated link.
Current parent company note: Parent-subsidiary relationship is current as of the most recent revision listed in the Update Log.